177Lu-EB-PSMA-617: Clinical Trials

3 trials of 177Lu-EB-PSMA-617, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 unknown. 1 Early Phase 1, 1 Not applicable, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 11Unknown 1
Not applicable1Unknown 1
Phase 11Unknown 1

Follow 177Lu-EB-PSMA-617: new trials by email Literature Review of 177Lu-EB-PSMA-617 trials Research Report on 177Lu-EB-PSMA-617

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Diagnosis of Renal Cell Carcinoma on 68Ga-PSMA PET-CT and Radioligand Therapy With 177Lu-EB-PSMA-617
68Ga-PSMA, 1.85GBq (50 mCi) of 177Lu-EB-PSMA-617 - Renal Cell Carcinoma
Not applicableUnknownPeking Union Medical College Hospital402021-12-012021-12-28
Diagnosis of Adenoid Cystic Carcinoma on 68Ga-PSMA-617 PET-CT and Therapy With 177Lu-EB-PSMA-617
68Ga-PSMA, 1.85GBq (50 mCi) of 177Lu-EB-PSMA-617 - Adenoid Cystic Carcinoma
Early Phase 1UnknownPeking Union Medical College Hospital402020-09-012021-03-23
177Lu-EB-PSMA617 in Patients With Metastatic Castration-resistant Prostate Cancer
177Lu-EB-PSMA-617 - Metastatic Castration-resistant Prostate Cancer
Phase 1UnknownPeking Union Medical College Hospital302017-12-012018-01-18

Conditions studied

Carcinoma, Adenoid Cystic (1)  ·  Carcinoma, Renal Cell (1)

Sponsors

Peking Union Medical College Hospital (3)

Countries

China (3)

Top investigators

Zhaohui Zhu, MD (2)  ·  Zhaohui Zhu, MD,PHD (1)

Results publications

PMID 35984529

NIH funding

ZIAEB000073 (1)